Immunotherapy for Nasopharyngeal Carcinoma: The Earlier the Better.

Bossi, Paolo; Gurizzan, Cristina; Chan, Anthony

Bossi, Paolo; Gurizzan, Cristina; Chan, Anthony.

Affiliation

Bossi P; Department of Biomedical Sciences, IRCCS Humanitas Research Hospital, Milan, Italy.
Gurizzan C; IRCCS Humanitas Research Hospital, Milan, Italy.
Chan A; Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia, ASST-Spedali Civili, Brescia, Italy.

JAMA ; 330(20): 1954-1955, 2023 11 28.

Article in En | MEDLINE | ID: mdl-38015229

Subject(s)

Antineoplastic Agents, Immunological; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Humans; Immunotherapy/methods; Nasopharyngeal Carcinoma/drug therapy; Nasopharyngeal Carcinoma/therapy; Nasopharyngeal Neoplasms/drug therapy; Nasopharyngeal Neoplasms/therapy; Antineoplastic Agents, Immunological/therapeutic use; Time-to-Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Nasopharyngeal Neoplasms / Antineoplastic Agents, Immunological / Nasopharyngeal Carcinoma Limits: Humans Language: En Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google